General and specific considerations as to why osteoporosis-related care is often suboptimal
General and specific considerations as to why osteoporosis-related care is often suboptimal
Purpose of Review: The assessment of fracture risk and use of antiosteoporosis medications have increased greatly over the last 20–30 years. However, despite this, osteoporosis care remains suboptimal worldwide. Even in patients who have sustained a fragility fracture, fewer than 20% actually receive appropriate antiosteoporosis therapy in the year following the fracture. There is also evidence that treatment rates have declined substantially in the last 5–10 years, in many countries. The goal of this article is to consider the causes for this decline and consider how this situation could be remedied. Recent Findings: A number of possible reasons, including the lack of prioritisation of osteoporosis therapy in ageing populations with multimorbidity, disproportionate concerns regarding the rare side effects of anti-resorptives and adverse changes in reimbursement in the USA, have been identified as contributing factors in poor osteoporosis care. Summary: Improved secondary prevention strategies; screening measures (primary prevention) and appropriate, cost-effective guideline and treatment threshold development could support the optimisation of osteoporosis care and prevention of future fractures.
Adverse effects, Epidemiology, Fracture, Osteoporosis, Policy, Treatment gap
38-46
Curtis, Elizabeth
12aba0c3-1e9e-49ef-a7e9-3247e649cdd6
Woolford, Stephen
fbecb815-4294-45c2-a735-6c3ac9739b96
Holmes, Claire
587ccc2d-5cca-407c-9c35-7a5eb465e8fa
Cooper, Cyrus
e05f5612-b493-4273-9b71-9e0ce32bdad6
Harvey, Nicholas
ce487fb4-d360-4aac-9d17-9466d6cba145
February 2020
Curtis, Elizabeth
12aba0c3-1e9e-49ef-a7e9-3247e649cdd6
Woolford, Stephen
fbecb815-4294-45c2-a735-6c3ac9739b96
Holmes, Claire
587ccc2d-5cca-407c-9c35-7a5eb465e8fa
Cooper, Cyrus
e05f5612-b493-4273-9b71-9e0ce32bdad6
Harvey, Nicholas
ce487fb4-d360-4aac-9d17-9466d6cba145
Curtis, Elizabeth, Woolford, Stephen, Holmes, Claire, Cooper, Cyrus and Harvey, Nicholas
(2020)
General and specific considerations as to why osteoporosis-related care is often suboptimal.
Current Osteoporosis Reports, 18 (1), .
(doi:10.1007/s11914-020-00566-7).
Abstract
Purpose of Review: The assessment of fracture risk and use of antiosteoporosis medications have increased greatly over the last 20–30 years. However, despite this, osteoporosis care remains suboptimal worldwide. Even in patients who have sustained a fragility fracture, fewer than 20% actually receive appropriate antiosteoporosis therapy in the year following the fracture. There is also evidence that treatment rates have declined substantially in the last 5–10 years, in many countries. The goal of this article is to consider the causes for this decline and consider how this situation could be remedied. Recent Findings: A number of possible reasons, including the lack of prioritisation of osteoporosis therapy in ageing populations with multimorbidity, disproportionate concerns regarding the rare side effects of anti-resorptives and adverse changes in reimbursement in the USA, have been identified as contributing factors in poor osteoporosis care. Summary: Improved secondary prevention strategies; screening measures (primary prevention) and appropriate, cost-effective guideline and treatment threshold development could support the optimisation of osteoporosis care and prevention of future fractures.
Text
BC Osteoporosis Care Suboptimal_Current Osteoporosis Reports 2019_10_29_submitted
- Accepted Manuscript
More information
Accepted/In Press date: 6 January 2020
e-pub ahead of print date: 26 February 2020
Published date: February 2020
Additional Information:
Funding Information:
We would like to thank the Medical Research Council (UK), National Institute for Health Research, Wellcome Trust, Versus Arthritis, Royal Osteoporosis Society and International Osteoporosis Foundation for supporting this work. This article includes text reproduced/adapted, with permission from [ 71 ] and [ 72 ].
Publisher Copyright:
© 2020, The Author(s).
Keywords:
Adverse effects, Epidemiology, Fracture, Osteoporosis, Policy, Treatment gap
Identifiers
Local EPrints ID: 436941
URI: http://eprints.soton.ac.uk/id/eprint/436941
PURE UUID: ab7a9f14-4bd2-4c3b-8994-9d6cba534c59
Catalogue record
Date deposited: 14 Jan 2020 17:31
Last modified: 18 Mar 2024 05:12
Export record
Altmetrics
Contributors
Author:
Stephen Woolford
Author:
Claire Holmes
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics
